Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Change in Inventory: 2014-2016

Historic Change in Inventory for Viridian Therapeutics, Inc.\DE (VRDN) over the last 3 years, with Dec 2016 value amounting to $2,000.

  • Viridian Therapeutics, Inc.\DE's Change in Inventory rose 101.13% to $2,000 in Q4 2016 from the same period last year, while for Dec 2016 it was -$123,000, marking a year-over-year decrease of 1637.50%. This contributed to the annual value of -$123,000 for FY2016, which is 1637.50% down from last year.
  • Latest data reveals that Viridian Therapeutics, Inc.\DE reported Change in Inventory of $2,000 as of Q4 2016, which was up 101.32% from -$151,000 recorded in Q3 2016.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Change in Inventory registered a high of $206,000 during Q2 2015, and its lowest value of -$232,000 during Q1 2014.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Change in Inventory averaged around -$24,417, with its median value being -$25,500 (2014).
  • Over the last 5 years, Viridian Therapeutics, Inc.\DE's Change in Inventory had its largest YoY gain of 202.94% in 2015, and its largest YoY loss of 541.03% in 2015.
  • Quarterly analysis of 3 years shows Viridian Therapeutics, Inc.\DE's Change in Inventory stood at -$53,000 in 2014, then crashed by 233.96% to -$177,000 in 2015, then soared by 101.13% to $2,000 in 2016.
  • Its Change in Inventory stands at $2,000 for Q4 2016, versus -$151,000 for Q3 2016 and -$56,000 for Q2 2016.